NIH-funded research R01 grant

How cell enzymes called kinases change shape to control activity

Official title: Multiscale Modeling of Protein Kinase Structure, Catalysis and Allostery

Funded at University of Texas Arlington · NIH-11298330 · Data updated 2026-11-12

This work uses computer modeling, machine learning, and lab experiments to learn how protein kinases change shape and control cell signals, which could help people with cancers and metabolic disorders.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startSeptember 15, 2019
Project endDecember 31, 2029
Funding year2026
Award (this year)$341,712
NIH project number2R01GM132481-05A1
Project IDNIH-11298330 on NIH RePORTER

Who could benefit from this research

Could help

People with cancers, insulin resistance/diabetes, or other conditions tied to abnormal kinase signaling could ultimately benefit from therapies informed by this research.

Less likely to help

Patients whose conditions are unrelated to kinase signaling or do not involve these pathways are unlikely to see direct benefit from this specific work.

What this research studies

Researchers combine large-scale computer simulations with machine learning and targeted laboratory experiments to map the movements and regulatory switches of protein kinases such as AKT and AMP kinase. The team will connect small-scale chemical events at active sites to larger protein shape changes to show how dynamics tune enzyme activity. Experimental validation will be used alongside simulations to ensure the predicted mechanisms reflect real molecules. Findings aim to highlight precise regulatory sites that could guide development of better, more selective kinase-targeting therapies.

Why it matters

Potential benefit: If successful, this work could reveal new molecular targets and strategies for designing drugs that more precisely modulate kinase activity, potentially improving treatments for cancers, diabetes, and other kinase-linked diseases.

How similar studies have gone: Related computational and experimental studies have improved understanding of kinases, but this integrated multiscale simulation plus machine-learning approach to allostery is relatively novel.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: Nam, Kwangho — University of Texas Arlington
  • Study coordinator: Nam, Kwangho

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.